The Inquiry has published its fifth report and recommendations following its investigation into procurement.
You are using a web browser with JavaScript disabled. Some of the features of this website may not function as intended.
[Automatic translation disclaimer]
Witness Statement provided by Andrew Evans, Chief Pharmaceutical Officer for Wales, dated 14/07/2024.
Scottish Care – Change in RLR – Module 2A and Module 6 – 5 September 2025
Counsel to the Inquiry’s note for the Second Preliminary Hearing for Module 9, dated 18 August 2025.